Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 31, 2011. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, rather than a comprehensive financial results report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to reporting specific share transactions and does not contain financial statements or performance metrics.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document solely discloses a change in share ownership by a director.
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, outlook, risk factors, or discussion of contingencies. It is a regulatory disclosure of a specific transaction.
Important Facts for Investors
- Transaction Type: A gift of 118,000 Ordinary shares in GlaxoSmithKline plc.
- Parties Involved: Mr. A P Witty (Director) transferred shares to his wife (Connected Person).
- Date of Transaction: March 31, 2011.
- Notification Date: The company was advised of the transaction on March 31, 2011.
- Regulatory Basis: Notified in accordance with Disclosure Rule 3.1.4R(1)(a) and (c).